Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Cancer-associated Fibroblasts: An Emerging Target Of Anti-cancer Immunotherapy
T. Liu, Chencheng Han, S. Wang, Panqi Fang, Zhifei Ma, Lin Xu, R. Yin
Published 2019 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Among all the stromal cells that present in the tumor microenvironment, cancer-associated fibroblasts (CAFs) are one of the most abundant and critical components of the tumor mesenchyme, which not only provide physical support for tumor cells but also play a key role in promoting and retarding tumorigenesis in a context-dependent manner. CAFs have also been involved in the modulation of many components of the immune system, and recent studies have revealed their roles in immune evasion and poor responses to cancer immunotherapy. In this review, we describe our current understanding of the tumorigenic significance, origin, and heterogeneity of CAFs, as well as the roles of different CAFs subtypes in distinct immune cell types. More importantly, we highlight potential therapeutic strategies that target CAFs to unleash the immune system against the tumor.
This paper references
Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma
Hideyuki Takahashi (2015)
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
P. Chomarat (2000)
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
V. Kumar (2017)
Docetaxel conjugate nanoparticles that target α-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis.
M. Murakami (2013)
An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells.
Joshua D. Freedman (2018)
Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment
L. Danelli (2015)
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Matthew Kraman (2010)
Transforming growth factor - beta signaling in
Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
Y. Deng (2017)
Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling
W. Tan (2011)
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
A. Orimo (2005)
Epigenetic silencing of microRNA-149 in cancer-associated Liu et al
P Li (2019)
EMT and Dissemination Precede Pancreatic Tumor Formation
A. Rhim (2012)
Transforming Growth Factor-β1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma
M. Löhr (2001)
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
D. Reardon (2006)
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li (2017)
Regulation of the anti-tumour immune response by cancer-associated fibroblasts.
James Harper (2014)
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells.
A. Lo (2015)
CD10GPR77 Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
D. Lambrechts (2018)
Transforming Growth Factor-β Signaling in Immunity and Cancer.
E. Batlle (2019)
Overexpression of TGF-β by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer
Y. Aoyagi (2004)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
D. Johnson (2018)
T cell exclusion, immune privilege, and the tumor microenvironment
J. Joyce (2015)
Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma.
M. Löhr (2001)
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen
H. Brechbuhl (2016)
Fibroblasts in the Tumor Microenvironment: Shield or Spear?
Twana Alkasalias (2018)
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
W. Chen (2003)
Bonneau C , et al : miR 200 - regulated CXCL 12 beta promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
AM Givel (2018)
A history of exploring cancer in context
Shelly Maman (2018)
Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens.
J. Zhang (2013)
The impact of the extracellular matrix on inflammation
L. Sorokin (2010)
Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer
Cynthia E. Weber (2014)
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Shicheng Su (2018)
TGF-β1 Attenuates the Acquisition and Expression of Effector Function by Tumor Antigen-Specific Human Memory CD8 T Cells
M. Ahmadzadeh (2005)
Immunosuppressive activities of adenosine in cancer.
B. Allard (2016)
Smooth muscle actin‐expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin‐1 and induction of poor prognosis factors
J. Valach (2012)
Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis
G. Comito (2019)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
M. Sherman (2014)
The pancreatic stellate cell: a star on the rise in pancreatic diseases.
M. Omary (2007)
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
S. Mariathasan (2018)
Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo.
S. Vicent (2012)
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
L. Wang (2013)
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Abasi E Ene-Obong (2013)
Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer
Rongsheng Zhang (2019)
Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis.
Y. Wei (2017)
Immunological hallmarks of stromal cells in the tumour microenvironment
S. Turley (2015)
The polarization of immune cells in the tumour environment by TGFβ
R. Flavell (2010)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth (2017)
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
P. Li (2015)
PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity.
I. Pinchuk (2008)
SS Donatelli (2019)
Identification of fibroblast heterogeneity in the tumor microenvironment
H. Sugimoto (2006)
Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression.
Fieke E. M. Froeling (2011)
Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.
T. Mace (2013)
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.
Andrew D. Rhim (2014)
Cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer
S Su (2018)
TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells
Sarah S. Donatelli (2014)
Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1
N. Cohen (2017)
Evidence that fibroblasts derive from epithelium during tissue fibrosis.
M. Iwano (2002)
TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells.
M. Ahmadzadeh (2005)
TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
A. Chakravarthy (2018)
Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1
M. Dikov (2005)
Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury
S. Dulauroy (2012)
FAP Delineates Heterogeneous and Functionally Divergent Stromal Cells in Immune-Excluded Breast Tumors
V. Cremasco (2018)
Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5
Ziqian Li (2019)
phase II study results
DA Reardon (2019)
H. V. D. Togt (2003)
TGF-beta-inducible microRNA-183 silences tumor-associated natural killer cells
SS Donatelli (2014)
The lung microenvironment: an important regulator of tumour growth and metastasis
N. Altorki (2018)
Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma
Andrew J. Gunderson (2019)
Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer
Y. Ino (2013)
CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions
P. Barth (2001)
Hepatic stellate cells in liver development, regeneration, and cancer.
C. Yin (2013)
Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
M. Lakins (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Ana Costa (2018)
Breast carcinoma-associated fibroblasts rarely contain p53 mutations or chromosomal aberrations.
A. N. Hosein (2010)
Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts
Jean Albrengues (2015)
Carcinoma-associated fibroblasts: orchestrating the composition of malignancy.
Philippe Gascard (2016)
Turning foes to friends: targeting cancer-associated fibroblasts
Xueman Chen (2018)
IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.
H. Kitamura (2005)
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.
Neta Erez (2010)
Alteration of the Tumor Stroma Using a Consensus DNA Vaccine Targeting Fibroblast Activation Protein (FAP) Synergizes with Antitumor Vaccine Therapy in Mice
Elizabeth K Duperret (2018)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
K. Olive (2009)
Tumoral Immune Suppression by Macrophages Expressing Fibroblast Activation Protein-α and Heme Oxygenase-1
J. N. Arnold (2013)
Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
Yusheng Cheng (2018)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
F Calvo (2013)
Macrophage-secreted TGF-β1 contributes to fibroblast activation and ureteral stricture after ablation injury.
E. Ueshima (2019)
Interleukin‐6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
H. Kitamura (2017)
A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion
A. Labernadie (2017)
miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Anne-Marie Givel (2018)
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.
D. A. Thomas (2005)
Recruitment of Mesenchymal Stem Cells Into Prostate Tumors Promotes Metastasis
Y. Jung (2013)
Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
M. Bartoschek (2018)
Turning 'sweet' on immunity: galectin–glycan interactions in immune tolerance and inflammation
G. Rabinovich (2009)
Macrophage secreted TGF-beta1 contributes to fibroblast activation and ureteral stricture following ablation injury
E Ueshima (2019)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
G. Zalcman (2016)
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
E. W. Roberts (2013)
Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization.
N. Kobayashi (2010)
Mechano-Signal Transduction in Mesenchymal Stem Cells Induces Prosaposin Secretion to Drive the Proliferation of Breast Cancer Cells.
Seiichiro Ishihara (2017)
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
Stromal myofibroblasts are drivers of invasive cancer growth
O. De Wever (2008)
Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients
Cheng Wang (2018)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail (2013)
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
D. Gabrilovich (1996)
Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
Jana de Sostoa (2019)
Modulation of macrophage phenotype by cell shape
Frances Y. McWhorter (2013)
Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression.
Y. Yamamura (2015)
Are Mast Cells MASTers in Cancer?
G. Varricchi (2017)
tissue is related to poor outcome in prostate cancer patients
M Iwano (2009)
Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.
Y. Ma (2013)
Fusion of Dendritic Cells and Cancer-Associated Fibroblasts for Activation of Anti-Tumor Cytotoxic T Lymphocytes.
Liwen Qian (2018)
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
Y. Ohshio (2015)
Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages
Hideyuki Takahashi (2017)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
L. De Monte (2011)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer (2015)
Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer
Gemma Ferrer-Mayorga (2016)
Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma
Nobuhide Higashino (2019)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.
R. Meisel (2004)
The biology and function of fibroblasts in cancer
R. Kalluri (2016)
Cancer-associated fibroblasts and CD163-positive macrophages in oral squamous cell carcinoma: their clinicopathological and prognostic significance.
Nobuyuki Fujii (2012)
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
T. Sakai (2018)
Cancer‐associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients
M. Herrera (2013)
The role of endothelial-to-mesenchymal transition in cancer progression
S. Potenta (2008)
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
Christine Feig (2013)
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.
E. Zeisberg (2007)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.
B. Özdemir (2015)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
D. Öhlund (2017)
Fibroblast heterogeneity in the cancer wound
D. Öhlund (2014)
Response to Comment on “Characterization of Human Lung Tumor-Associated Fibroblasts and Their Ability to Modulate the Activation of Tumor-Associated T Cells”
M. Nazareth (2007)
Erratum: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (Nature Medicine 2, 1096-1103 (1996))
D. Gabrilovich (1996)
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.
I. Acerbi (2015)
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
Sunitha Kakarla (2013)
Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties.
Martin Augsten (2014)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
Xuguang Yang (2016)
Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts
M. Vizoso (2015)
Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts
Yasushi Kojima (2010)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.
M. Loeffler (2006)
Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients
P. Wikström (2009)
FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation.
J. Zhang (2011)
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
J. Jacobs (2018)
The IL-6–STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression
Q. Zhu (2014)
Cancer-associated fibroblasts in gastrointestinal cancer
H. Kobayashi (2019)
Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors
Constantin Jotzu (2011)
IL-6-STAT3 Controls Intracellular MHC Class II αβ Dimer Level through Cathepsin S Activity in Dendritic Cells
H. Kitamura (2005)
Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity
T. Li (2013)
A history of exploring cancer
S Maman (2018)
Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
M. Augsten (2014)
Fibroblast heterogeneity: implications for human disease
M. Lynch (2018)
Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
J. Khalili (2012)
Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
Linda Ziani (2018)
Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma
Tomonari Kinoshita (2013)
Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation.
I. Gutcher (2011)
Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.
Xueqian Zhuang (2019)
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of Liu et al
AJ CJWE-OA. (2019)
This paper is referenced by
[Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
Chongbiao Huang (2020)
Emerging Therapeutic RNAs for the Targeting of Cancer Associated Fibroblasts
Laura Santana-Viera (2020)
Borderline Microenvironment Fibrosis Is a Novel Poor Prognostic Marker of Oral Squamous Cell Carcinoma
Kei Tsuchihashi (2020)
Epigenetic heterogeneity in cancer
Mingzhou Guo (2019)
Endoplasmic Reticulum Stress Pathway, the Unfolded Protein Response, Modulates Immune Function in the Tumor Microenvironment to Impact Tumor Progression and Therapeutic Response
M. U. Ramirez (2019)
The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer Cells
Leslimar Rios-Colon (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghban (2020)
Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
Nicholas Gravbrot (2019)
Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.
Rama Rao Malla (2020)
Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities
Patrick Freeman (2020)
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
D. Nalini (2019)
The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy
Miles Piper (2020)
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
A. Sebastian (2020)
Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours
Y. Cheng (2020)
Effects of Nicotinamide on Cervical Cancer-Derived Fibroblasts: Evidence for Therapeutic Potential
Reem N Hassan (2020)
Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth
S. Brézillon (2020)
Recent Advances in 3D Bioprinted Tumor Microenvironment
Jinseung Bae (2020)
3D Pancreatic Tissue Modeling in vitro: Advances and Prospects
M. Kim (2020)
Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment
J. Norton (2020)
An overview of the role of interleukin-8 in colorectal cancer.
Soroush Najdaghi (2020)
Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis
P. Lin (2020)
The Role of Tubule-Interstitial Crosstalk in Renal Injury and Recovery.
I. Schiessl (2020)
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Xueke Shi (2020)
Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
Varintra E Krisnawan (2020)
Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
R. Mhaidly (2020)
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
N. Erin (2020)
ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA)
W. Jung (2020)
Lipoproteins and the Tumor Microenvironment.
Akpedje S Dossou (2020)
Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts
J. Wang (2020)
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Q. Qiu (2020)
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
M. Ansems (2020)
Obesity-Activated Lung Stomal Cells Promote Myeloid-Lineage Cell Accumulation and Breast Cancer Metastasis
Lauren E. Hillers-Ziemer (2020)See more